Pemetrexed Induced Life-threatening Anaphylaxis

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. The American Society for Clinical Oncology (ASCO) recommends platinum based regimens as the first-line of treatment for NSCLC. Pemetrexed, an antifolate agent, has been approved by the ASCO for the treatment of advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajasurya, Venkat, Pyakuryal, Bimatshu, Gunasekaran, Kulothungan, Sekar, Vijaykumar, Dhakal, Prajwal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818736/
https://www.ncbi.nlm.nih.gov/pubmed/31687290
http://dx.doi.org/10.7759/cureus.5514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818736/
https://www.ncbi.nlm.nih.gov/pubmed/31687290
http://dx.doi.org/10.7759/cureus.5514

Ejemplares similares